期刊文献+

美国药品标准管理模式研究 被引量:2

Study on Mode of Drug Standard in America
下载PDF
导出
摘要 目的为我国建立药品标准管理体系提供参考。方法通过研究美国药品标准的管理模式,探索其保证药品标准权威性、科学性、先进性的管理经验和特点,提出收获的几点启示。结果美国已基本形成完善的药品标准管理体系,健全的法律体系确保了USP-NF作为药品标准的权威性;独立专业的美国药典委员会对药品标准的科学管理、标准制定程序的公开透明、注重与公众的沟通及企业参与度等特点保证了药品标准的科学性;灵活的加速修订程序及各论更新计划调动各利益相关方参与标准的修订活动,保证了标准的先进性。结论我国应引入先进的标准管理理念,完善法律法规及标准的制定、修订程序,引入公众评议机制,逐渐强化企业在标准化活动中的主体地位,建立符合国情的药品标准管理体系。 Objective To provide references for establishing Chinese drug standard management system. Methods The mode of drug standard in America was briefly introduced. The managerial experience and features of maintaining the authority, scientificity and progressiveness of drug standard were explored and some revelations were put forward. Results The USA has basically developed the perfect drug standard management system. The robust legal system defines USP-NF as the authority of drug standard. The scientific management by United States Pharmacopeial Convention, transparency and communication with the public and participation of enterprises ensure the scientificity of standard. Flexible Accelerated Revision Processes and USP Monograph Update Program involve stakeholders to join in the revision activities of drug standard, thus ensuring the progressiveness of drug standard. Gorlclusiori We should bring in advanced management concept, improve related laws and regulations, drug standard establishment and revision process and introduce public review mechanism as well as intensify the main position of enterprises in standardization activities, thus establishing drug standard management system which conforms to national conditions.
出处 《中国药物警戒》 2014年第10期606-610,共5页 Chinese Journal of Pharmacovigilance
关键词 药品标准 药品标准管理体系 drug standard drug standard management system
  • 相关文献

参考文献8

  • 1CPG. Sec. 420.400 Performance of Tests for Compendial Require-ments on Compendial Products [EB/OL]. (2010-01-12) [2014-03-26].http://www .fda.gov/iceci/compliancemanuals/compliancepoli-cyguidancemanualAicm074370.htm.
  • 2USPC- Governance [EB/OL]. [2014-03-26]iittpy/www.usp.org/about~usp/leadership/govemance.
  • 3操洪欣.药品质量标准[EB/C)L].(2011-01-15)[2014-03-26].http://www.doc88.com/p-714689146410.html.
  • 4胡江滨对接国际标准促进中国医药产业升级-美国药品相关标准内容分析和制定情况介绍[EB/OL].(2010-12-02)[2014-03-26]. http://www.pharmacy.hc360.com/10daquan/secondmenu/Detail一yjbg5 .html.
  • 5USPC, USP Guideline for Submitting Requests for Revision to USP-NFV5 January 2011[EB/OL].(2011-05-27)[2014-03-26].http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/usp_rfr_general_info_for_aILsubmissions_v5Jan_2011.pdf.
  • 6USPC. PENDING MONOGRAPHS GUIDELINE [EB/OL].( 2011-ll-01)[2014-03-26].http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/2011-ll-01_pending_monographs_guideline_ver-sion_2.7.pdf.
  • 7USPC. USP Guideline on Use of Accelerated Processes for Revi-sions to the USP-NF Version 3.0 [EB/OL].( 2012-08-31)[2014-03-26].http^/www.usp.org/sites/default/files/usp_pdf/EN/USPNF/2012-08-3 l_guideline_on一use 一of一accelerated一processes 一v3 .pdf.
  • 8USPC.Advancing Health Through Public Standards-USP & FDA'sResponse to Heparin Crisis: A Timeline of Events [EB/OL]. [ 2014-03-26].http://www.usp.org/sites/default/files/usp_pdf/EN/vaIue-OfS tandards7heparinTimeline.pdf.

同被引文献9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部